Table 1.
Demographic and clinical characteristics of the patients.
| Parameters | Low-ACI (N = 46) | High-ACI (N = 46) | P |
|---|---|---|---|
| Age | 49.4 ± 11.6 | 60.9 ± 11.1 | < 0.001 |
| Gender, male (%) | 26 (56.5) | 22 (47.8) | 0.40 |
| Dialysis vintage (mo) | 12.3 ± 13.9 | 25.5 ± 27.8 | 0.04 |
| Body mass index (kg/m2) | 24.0 ± 3.9 | 24.5 ± 4.2 | 0.56 |
| Follow-up months | 35.3 ± 22.1 | 42.0 ± 29.6 | 0.43 |
| History of CV disease (%) | 8 (17.4) | 18 (39.1) | 0.02 |
| Diabetes (%) | 19 (41.3) | 31 (67.4) | 0.01 |
| Hypertension (%) | 46 (100) | 45 (97.8) | 1.00 |
| Smoking (%) | 18 (40.9) | 16 (35.6) | 0.60 |
| ACE inhibitor and/or ARB use (%) | 32 (69.6) | 36 (78.3) | 0.34 |
| Calcium channel blocker use (%) | 20 (43.5) | 13 (28.3) | 0.13 |
| Beta-blocker use (%) | 16 (34.8) | 18 (39.1) | 0.67 |
| Statin use (%) | 22 (48.9) | 24 (52.2) | 0.75 |
| Phosphate binder use (%) | 27 (58.7) | 23 (50.0) | 0.40 |
| Active vitamin D use (%) | 8 (17.4) | 3 (6.5) | 0.20 |
| Icodextrin use (%) | 14 (30.4) | 20 (50.0) | 0.06 |
| Dialytic Uf (mL/day) | 1,454 ± 109 | 1,396 ± 124 | 0.12 |
| Urine output (mL/day) | 406.8 ± 43.8 | 330.8 ± 50.2 | 0.23 |
| RRF (mL/min/1.73m2) | 3.6 ± 1.5 | 3.4 ± 1.6 | 0.52 |
| Weekly CCr (L/1.73m2) | 94.0 ± 1.04 | 89.8 ± 11.1 | 0.21 |
| High and high average transporter (%) | 18 (39.1) | 22 (44.0) | 0.63 |
| ACI | 5.8 ± 7.3 | 36.6 ± 13.4 | < 0.001 |
ACI: aortic calcification index; CV: cardiovascular; ACE: angiotensin-converting enzyme; ARB: angiotensin II receptor blocker; Uf: ultrafiltration; RRF: residual renal function; CCr: creatinine clearance.